OMICS: A Journal of Integrative Biology integrates global high-throughput and systems approaches to 21st century science from “cell to society” – seen from a post-genomics perspective.
The Journal is the only peer-reviewed forum covering all trans-disciplinary OMICS-related areas such as integrative (systems) biology and medicine, including but not limited to those specialties listed below.
In addition, OMICS encourages submission of reports on methods and resources underpinning integrative research, including but not limited to bioinformatics, computational biology, and biomedical informatics; data standards, meta-data, data sharing, databases, biobanks and cloud computing; methodological, statistical, and algorithmic developments; capacity building for developing world OMICS; applications of OMICS for personalized medicine (e.g., pharmacogenomics) and public health practice (e.g., vaccinomics); and social, legal and ethics analyses of OMICS technologies and post-genomics life science innovations.
OMICS: A Journal of Integrative Biology coverage includes:
- Biobanks and OMICS infrastructure science
- Developing world OMICS and capacity building
- Healthcare management and OMICS diagnostics
- Linkages between global health diplomacy and OMICS R&D
- OMICS and nanotechnology convergence
- OMICS and innovation in pharmaceutical and vaccine industry
- Personalized medicine
- Public health OMICS
- Sociomics and data-intensive sociology of life sciences
- OMICS and society
- Social, legal, political science and ethics research on OMICS technologies and post-genomics medicine
OMICS: A Journal of Integrative Biology is under the editorial leadership of Editor-in-Chief Vural Özdemir, MD, PhD, DABCP, Consultant, Innovation in Global Governance for Science, Technology and Health, Canada, and Global Communications Advisor, Spain, and other leading investigators. View the entire editorial board.
Audience: Integrative, ecosystem and cell biologists; multi-omics biotechnology researchers; precision medicine (nutrigenomics, vaccinomics, pharmacogenomics) scientists; bioinformaticians and computational biologists; medical doctors, nurses, healthcare professionals; government and policymakers; technology and innovation forecasters for post-genomics medicine and biotechnology futures; social and political scientists and ethicists interested in emerging biotechnologies; scholars in global health, among others.
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.